StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Teva Pharma (TEVA) PT Raised to $48 at UBS
September 7, 2026 5:26 AM
UBS analyst Ashwani Verma raised ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change